News: FDA approves new olopatadine hydrochloride (Patanase), a new nasal antihistamine - - RNweb

Nursing

Powered By Nursing
News: FDA approves new olopatadine hydrochloride (Patanase), a new nasal antihistamine
Publish date: May 1, 2008
Source: RN

Just in time for hay fever season, the FDA has approved Alcon's olopatadine hydrochloride (Patanase) spray for seasonal allergic rhinitis in patients 12 years of age and older. Multiple clinical trials demonstrated its safety and efficacy of action, and environmental tests on rhinitis patients showed a 30-minute onset time (with two sprays per nostril, twice daily) versus placebo. Sales will begin this May.

Health Care Business Daily. "Alcon's nasal spray approved for seasonal allergic rhinitis." 2008. http:// http://www.verusmed.com/articles/view/53723/?referer=/search/results (21 Apr. 2008).

Rate this article
Your original vote has been tallied and is included in the ratings results.
View our top pages
 Average rating for this page is: 0
Other Articles from RN
Chocolate lovers rejoice!
More fentanyl patch overdoses spur new warning
Profile of risk factors for Alzheimer's expanded
Innovations in Practice: Get moving to fight diabetes
Patients may benefit from new fibromyalgia drug
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here

RN
Stay Connected to RN • Issue Archive
• Subscribe to Enewsletter
Clinical Perspectives
AcneAdolescent MedicineAllergy & ImmunologyAlzheimer's DiseaseAsthmaBPHBreast CancerCardiologyCataractsChild Behavior & DevelopmentClinical PharmacologyContraceptionCorneal DiseaseCosmetic Dermatology Cosmetic SurgeryDepressionDermatologyDiabetesDry EyeEczema/Atopic DermatitisEndocrinologyEpilepsyErectile DysfunctionGastroenterologyGastroesophageal Reflux Disease (GERD) & Acid Peptic DiseaseGeriatricsGlaucomaGynecologic OncologyHIV/AIDSHormone TherapyHyperlipidemiaHypertensionImmunization/VaccinesInfectious DiseaseInternal MedicineIrritable Bowel Syndrome (IBS)Kidney & Bladder CancerLaser & Light Technology in DermatologyMaternal & Fetal MedicineMenopauseMigraineMultiple SclerosisNeurologyNutritionOb/Gyn SurgeryObesityOB/GYN & Women's HealthOncologyOphthalmologyOptometryOrthopedicsOsteoporosisParkinson's DiseasePathologyPediatricsPrimary Care MedicineProstate CancerPsoriasisPsychiatry & Behavioral HealthRadiologyRefractive SurgeryReproductive Endocrinology/InfertilityRetinal DiseaseRheumatoid ArthritisSkin CancerSleep DisordersSmoking-Related IllnessStrokeSurgeryUrinary Incontinence/Overactive BladderUrologic SurgeryUrology
Business Perspectives
Coding CounselorLiability & Risk ManagementHealth Care Information TechnologyPractice ManagementBusiness OperationsHuman Resources Health Law & PolicyManaged CarePersonal FinanceProducts
Popular Topics
CME/CECoding CounseloreNewslettersPatient Education CenterBlogsBlogsFormulary CounselorModernMedicine RadioSyndicationSurgical Video Center
Source: RN, 5/1/2008
Click here